March 21, 2025

Maternal overweight as risk factor for childhood leukemia in daughters

Maternal overweight as risk factor for childhood leukemia in daughters

The weight of expectant mothers could play a role in the development of acute lymphoblastic leukemia (ALL) in daughters – but not in sons. This has been shown by researchers at the German Cancer Research Center (DKFZ).

Bone marrow smear (large magnification) from a patient with acute lymphoblastic leukemia. (C) wikimedia/Furfur

Acute lymphoblastic leukemia is rare overall, but accounts for about a quarter of childhood cancers. To identify possible risk factors, a team led by Mahdi Fallah, DKFZ, together with colleagues from Lund University, analyzed data from almost 3 million births in Sweden over a period of 35 years. The data was taken from the Swedish nationwide family cancer registry.

During the study period, a total of 1,388 children in Sweden developed ALL. The results show that girls whose mothers were overweight or obese (BMI 25 and above) at the beginning of pregnancy had a 40 percent increased risk of developing ALL.

“Our results were also surprising to us,” says Mahdi Fallah, lead scientist of the study. ”They suggest that maternal obesity could be an overlooked risk factor for childhood leukemia – and that it is gender-specific.”

The researchers suspect that hormonal influences, particularly elevated estrogen levels during pregnancy, could play a role. Estrogens have been shown to affect gene expression and could increase the risk of leukemia in female offspring.

Encouragingly, the study showed no association between weight gain during pregnancy and ALL risk, which is a relief for expectant mothers concerned about their pregnancy weight gain.

The scientists are now planning further investigations to better understand the biological mechanisms behind this surprising sex-specific phenomenon. In the long term, the findings may lead to new prevention strategies. “Pregnancy is a crucial phase for a child’s health,” emphasizes Fallah. “Our results underscore the importance of educating expectant mothers about healthy lifestyle habits early on – not only for their own well-being, but also for that of their children.”

Jiaye Liu, Elham Kharazmi, Qunfeng Liang, Yafei Chen, Jan Sundquist, Kristina Sundquist and Mahdi Fallah: Maternal weight during pregnancy and risk of childhood acute lymphoblastic leukemia in offspring

Leukemia 2025, DOI: https://doi.org/10.1038/s41375-025-02517-6

Our latest News

discover more
Contracts signed for Heidelberg-Mannheim hospital network

Contracts signed for Heidelberg-Mannheim hospital network

It’s now official: the alliance between the two university hospitals in Heidelberg and Mannheim can start as planned on January 1 and begin its work. Press release from the Baden-Württemberg Ministry of Science, Research, and the Arts. Full Text in German below. Verträge zum Klinikverbund Heidelberg-Mannheim unterzeichnet Nun ist es offiziell: Der Verbund zwischen den […]

Cystic fibrosis research: AI-assisted evaluation of MRI images in chronic rhinosinusitis

Cystic fibrosis research: AI-assisted evaluation of MRI images in chronic rhinosinusitis

Persistent inflammation of the paranasal sinuses, chronic rhinosinusitis, is a common comorbidity in cystic fibrosis and significantly impairs quality of life. The working group led by Dr. Niclas Hagen, Institute for Medical Informatics at Heidelberg University’s Faculty of Medicine and Heidelberg University Hospital, is currently developing a method that uses AI to contribute to the […]

New Research Group Leader at the Max Planck Institute for Medical Research

New Research Group Leader at the Max Planck Institute for Medical Research

In March 2026, Kevin Jahnke will establish a research group on ‘Biomembrane Engineering’ at the new Heilbronn site of the Max Planck Institute for Medical Research. Its focus will be on engineering synthetic lipid nano- and microstructures, with the aim of investigating the biophysics of both cells and lipid vesicles.  Connecting biophysical insights with biotechnological […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp